TP53 and neoplasm: Interestingly, while TP53 mutations or alterations in the p53 pathway are invariably observed in chromosomally unstable tumors [31], only few other mutations have been reported as recurrent in these tumor subtypes, suggesting these multiple subclonal events might be only a “passenger” byproduct of p53 deficiency.